Chronic Urticaria: Antihistamines, Biologics, and BTK Inhibitors (New Webinar)
Published: February 13, 2026
Join us for a FREE webinar | April 16, 2026| 4 PM ET
Chronic urticaria is a complex and often persistent condition that presents ongoing management challenges for clinicians. Optimal care frequently requires a stepwise therapeutic approach, careful monitoring of treatment response, and familiarity with emerging therapies as the treatment landscape continues to evolve.
In this live webinar, Dr. Clinton Dunn will provide an evidence-based overview of chronic urticaria management for clinicians and other medical professionals. Topics will include the effective use and optimization of antihistamines, clinical scenarios in which escalation to biologic therapy should be considered, and the latest data on Bruton’s tyrosine kinase (BTK) inhibitors.
Speaker:
Clinton Dunn, MD
Clinton Dunn, MD, is a board-certified physician in pediatrics as well as allergy and immunology, practicing in the Norfolk and Hampton Roads area. He is affiliated with Children’s Specialty Group, which is part of Children’s Hospital of the King’s Daughters, and he is an assistant professor at Mason and Joan Brock Virginia Health Sciences Center at Old Dominion University. His clinical interests include allergic skin disease, asthma, pediatric anaphylaxis, inborn errors of immunity, and primary immune regulatory disorders. Dr. Dunn is involved in teaching medical students and residents, emphasizing evidence-based, cost-effective care.
This Advances webinar is in partnership with the American College of Allergy, Asthma & Immunology. ACAAI offers CMEs for physicians for this webinar. If you are a member of ACAAI, you can obtain CME through the member portal for the Advances webinars.
All attendees will be offered a certificate of attendance. No other continuing education credit is provided.
If you’re unable to attend the live session, registered participants will receive access to the on-demand recording and supplemental resources.
Sponsored by the American College of Allergy, Asthma and Immunology
